AJTMH Transactions of the Royal Society of Tropical Medicine and Hygiene
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am. J. Trop. Med. Hyg., 56(5), 1997, pp. 522-525
Copyright © 1997 by The American Society of Tropical Medicine and Hygiene

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sundar, S.
Right arrow Articles by Murray, H. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sundar, S.
Right arrow Articles by Murray, H. W.

Circulating T Helper 1 (Th1) Cell- and Th2 Cell-Associated Cytokines in Indian Patients with Visceral Leishmaniasis

Shyam Sundar, Steven G. Reed, Sashi Sharma, Amit Mehrotra AND Henry W. Murray
Kala-Azar Medical Research Center, Department of Medicine, Institute of Medical Sciences, Banaras Hindu University, Varanasi, India; Corixa Corporation, Seattle, Washington; Department of Medicine, Cornell University Medical College, New York, New York

Sera from 61 Indian patients with visceral leishmaniasis caused by infection with Leishmania donovani were tested for the presence of T helper 1 (Th1) cell-(interferon-{gamma} [IFN-{gamma}]) and Th2 cell-associated cytokines (interleukin-4 [IL-4] and IL-10). The IFN-{gamma} activity was detected in 53%, IL-4 in 84%, and IL-10 in 56% of patient samples. Sera from 10 healthy Indian controls showed detectable IFN-{gamma} in 90%, IL-4 in 10%, and IL-10 in 20%; corresponding percentages for sera from eight healthy American controls were 100%, 12%, and 0%, respectively. Quantitative data for the 61 patients compared with the 10 Indian controls indicated comparable mean levels of IFN-{gamma}, but three- and 13-fold increases in IL-10 and IL-4, respectively. Undetectable IFN-{gamma} activity, observed in 47% of patients, was associated with the presence IL-4 alone or in combination with IL-10 but not with IL-10 alone. In patients who had failed prior therapy (n = 29) compared with previously untreated patients (n = 32), IFN-{gamma} levels were 67% lower and IL-4 levels were two-fold higher; IL-10 activity was comparable. These results using peripheral blood support the presence of a suppressive Th2 cell-associated immune response in symptomatic Indian kala-azar and point to a possible role for IL-4.




This article has been cited by other articles:


Home page
J. Immunol.Home page
A. Banerjee, M. De, and N. Ali
Complete Cure of Experimental Visceral Leishmaniasis with Amphotericin B in Stearylamine-Bearing Cationic Liposomes Involves Down-Regulation of IL-10 and Favorable T Cell Responses
J. Immunol., July 15, 2008; 181(2): 1386 - 1398.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
E. McFarlane, C. Perez, M. Charmoy, C. Allenbach, K. C. Carter, J. Alexander, and F. Tacchini-Cottier
Neutrophils Contribute to Development of a Protective Immune Response during Onset of Infection with Leishmania donovani
Infect. Immun., February 1, 2008; 76(2): 532 - 541.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Saha, S. Mondal, R. Ravindran, S. Bhowmick, D. Modak, S. Mallick, M. Rahman, S. Kar, R. Goswami, S. K. Guha, et al.
IL-10- and TGF-beta-Mediated Susceptibility in Kala-azar and Post-kala-azar Dermal Leishmaniasis: The Significance of Amphotericin B in the Control of Leishmania donovani Infection in India
J. Immunol., October 15, 2007; 179(8): 5592 - 5603.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
I. L. K. Wong, K.-F. Chan, B. A. Burkett, Y. Zhao, Y. Chai, H. Sun, T. H. Chan, and L. M. C. Chow
Flavonoid Dimers as Bivalent Modulators for Pentamidine and Sodium Stiboglucanate Resistance in Leishmania
Antimicrob. Agents Chemother., March 1, 2007; 51(3): 930 - 940.
[Abstract] [Full Text] [PDF]


Home page
Postgrad. Med. J.Home page
T. V Piscopo and C. Mallia Azzopardi
Leishmaniasis.
Postgrad. Med. J., February 1, 2007; 83(976): 649 - 657.
[Abstract] [Full Text] [PDF]


Home page
Postgrad. Med. J.Home page
T V Piscopo and A C Mallia
Leishmaniasis.
Postgrad. Med. J., October 1, 2006; 82(972): 649 - 657.
[Abstract] [Full Text] [PDF]


Home page
Br Med BullHome page
M. T. M. Roberts
Current understandings on the immunology of leishmaniasis and recent developments in prevention and treatment
Br. Med. Bull., July 17, 2006; 75-76(1): 115 - 130.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
L. E. Rosas, A. A. Satoskar, K. M. Roth, T. L. Keiser, J. Barbi, C. Hunter, F. J. de Sauvage, and A. R. Satoskar
Interleukin-27R (WSX-1/T-Cell Cytokine Receptor) Gene-Deficient Mice Display Enhanced Resistance to Leishmania donovani Infection but Develop Severe Liver Immunopathology
Am. J. Pathol., January 1, 2006; 168(1): 158 - 169.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1997 by the American Society of Tropical Medicine and Hygiene.